BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
Novartis
Chubb
Colorcon
Cipla
QuintilesIMS
AstraZeneca
Teva
US Army

Generated: January 22, 2018

DrugPatentWatch Database Preview

ONDANSETRON HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Ondansetron Hydrochloride, and what generic alternatives are available?

Ondansetron Hydrochloride is a drug marketed by Accord Hlthcare, Apotex Inc, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Lannett, Luitpold, Mylan Labs Ltd, Pliva Hrvatska Doo, Qilu Pharm Co Ltd, Sagent Pharms, Sandoz Inc, Sun Pharm Inds (in), Teva, West-ward Pharms Int, Wockhardt, Amneal Pharms, Apotex, Aurobindo Pharma, Silarx, Taro, Chartwell Molecules, Dr Reddys Labs Ltd, Glenmark Generics, Hikma Intl Pharms, Ipca Labs Ltd, Mylan, Natco Pharma Ltd, Sandoz, Emcure Pharms Ltd, Sun Pharm Inds Ltd, and Taro Pharms Ireland. and is included in sixty-eight NDAs.

The generic ingredient in ONDANSETRON HYDROCHLORIDE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ondansetron hydrochloride profile page.
Drug patent expirations by year for ONDANSETRON HYDROCHLORIDE
Pharmacology for ONDANSETRON HYDROCHLORIDE

US Patents and Regulatory Information for ONDANSETRON HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 076252-003 Jun 25, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Molecules ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077303-004 Jun 25, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride SOLUTION;ORAL 077009-001 Nov 30, 2007 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 078244-001 Apr 23, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Intl Pharms ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077545-001 Sep 6, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva Hrvatska Doo ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077112-002 Jun 25, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 076183-001 Dec 26, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Intl Pharms ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077545-002 Sep 6, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 076930-002 Jun 25, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva Hrvatska Doo ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077112-003 Jun 25, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Fuji
McKesson
Mallinckrodt
Deloitte
Chubb
Novartis
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot